BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 27310569)

  • 21. Epidemiology and disease burden of tuberous sclerosis complex in France: A population-based study based on national health insurance data.
    Fagnani F; Laurendeau C; de Zelicourt M; Marshall J
    Epilepsia Open; 2022 Dec; 7(4):633-644. PubMed ID: 36029029
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epidemiology, healthcare resource use, and mortality in patients with tuberous sclerosis complex: A population-based study on German health insurance data.
    Strzelczyk A; Rosenow F; Zöllner JP; Simon A; Wyatt G; Holland R; Schubert-Bast S
    Seizure; 2021 Oct; 91():287-295. PubMed ID: 34265583
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tuberous sclerosis complex: genotype/phenotype correlation of retinal findings.
    Aronow ME; Nakagawa JA; Gupta A; Traboulsi EI; Singh AD
    Ophthalmology; 2012 Sep; 119(9):1917-23. PubMed ID: 22608477
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Direct and indirect costs and cost-driving factors of Tuberous sclerosis complex in children, adolescents, and caregivers: a multicenter cohort study.
    Grau J; Zöllner JP; Schubert-Bast S; Kurlemann G; Hertzberg C; Wiemer-Kruel A; Bast T; Bertsche A; Bettendorf U; Fiedler B; Hahn A; Hartmann H; Hornemann F; Immisch I; Jacobs J; Kieslich M; Klein KM; Klotz KA; Kluger G; Knuf M; Mayer T; Marquard K; Meyer S; Muhle H; Müller-Schlüter K; Noda AH; Ruf S; Sauter M; Schlump JU; Syrbe S; Thiels C; Trollmann R; Wilken B; Willems LM; Rosenow F; Strzelczyk A
    Orphanet J Rare Dis; 2021 Jun; 16(1):282. PubMed ID: 34154622
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Manifestations of Tuberous Sclerosis Complex: The Experience of a Provincial Clinic.
    Wilbur C; Sanguansermsri C; Chable H; Anghelina M; Peinhof S; Anderson K; Steinbok P; Singhal A; Datta A; Connolly MB
    Can J Neurol Sci; 2017 Jan; 44(1):35-43. PubMed ID: 28004629
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The incidence and healthcare costs of persistent postoperative pain following lumbar spine surgery in the UK: a cohort study using the Clinical Practice Research Datalink (CPRD) and Hospital Episode Statistics (HES).
    Weir S; Samnaliev M; Kuo TC; Ni Choitir C; Tierney TS; Cumming D; Bruce J; Manca A; Taylor RS; Eldabe S
    BMJ Open; 2017 Sep; 7(9):e017585. PubMed ID: 28893756
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kidney Imaging Surveillance in Commercially Insured Patients With Tuberous Sclerosis Complex.
    Goedken AM; Samuels JA; Sato TS; Harshman LA
    Pediatr Neurol; 2021 Apr; 117():21-26. PubMed ID: 33647778
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lymphangioleiomyomatosis and Tuberous Sclerosis Complex in Quebec: Prevalence and Health-care Utilization.
    Kristof AS; Zhi Li P; Major P; Landry JS
    Chest; 2015 Aug; 148(2):444-449. PubMed ID: 25789699
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Review of Investigations for Patients With Tuberous Sclerosis Complex Who Were Referred to the Tuberous Sclerosis Clinic at The Hospital for Sick Children: Identifying Gaps in Surveillance.
    Alsowat D; Zak M; McCoy B; Kabir N; Al-Mehmadi S; Chan V; Whitney R
    Pediatr Neurol; 2020 Jan; 102():44-48. PubMed ID: 31362847
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Resource use and direct medical costs of acute respiratory illness in the UK based on linked primary and secondary care records from 2001 to 2009.
    Meier GC; Watkins J; McEwan P; Pockett RD
    PLoS One; 2020; 15(8):e0236472. PubMed ID: 32760071
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Resource utilization in children with tuberous sclerosis complex and associated seizures: a retrospective chart review study.
    Lennert B; Farrelly E; Sacco P; Pira G; Frost M
    J Child Neurol; 2013 Apr; 28(4):461-9. PubMed ID: 22772159
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evolving Strategies in the Treatment of Tuberous Sclerosis Complex-associated Angiomyolipomas (TSC-AML).
    Kapoor A; Girard L; Lattouf JB; Pei Y; Rendon R; Card P; So A
    Urology; 2016 Mar; 89():19-26. PubMed ID: 26723178
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patients' and physicians' awareness of clinical symptoms and disease severity in tuberous sclerosis complex.
    Sauter M; Weber L; Jung D; Weremko M; Bachmann D; Fischereder M; Bachmann HS
    Orphanet J Rare Dis; 2024 Mar; 19(1):106. PubMed ID: 38459571
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Health care resource utilization and costs in a commercially insured population of patients with bipolar disorder type I and frequent psychiatric interventions.
    Bagalman E; Muser E; Choi JC; Durden E; Macfadden W; Haskins JT; Dirani R
    Clin Ther; 2011 Oct; 33(10):1381-1390.e4. PubMed ID: 22000656
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trends in the prevalence of tuberous sclerosis complex manifestations: an epidemiological study of 166 Japanese patients.
    Wataya-Kaneda M; Tanaka M; Hamasaki T; Katayama I
    PLoS One; 2013; 8(5):e63910. PubMed ID: 23691114
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A population-based study to estimate survival and standardized mortality of tuberous sclerosis complex (TSC) in Taiwan.
    Peng JH; Tu HP; Hong CH
    Orphanet J Rare Dis; 2021 Aug; 16(1):335. PubMed ID: 34344419
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Renal manifestations of tuberous sclerosis complex.
    O'Hagan AR; Ellsworth R; Secic M; Rothner AD; Brouhard BH
    Clin Pediatr (Phila); 1996 Oct; 35(10):483-9. PubMed ID: 8902325
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Causes of mortality in individuals with tuberous sclerosis complex.
    Amin S; Lux A; Calder N; Laugharne M; Osborne J; O'callaghan F
    Dev Med Child Neurol; 2017 Jun; 59(6):612-617. PubMed ID: 27935023
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characteristics and healthcare situation of adult patients with tuberous sclerosis complex in German epilepsy centers.
    Hamer HM; Pfäfflin M; Baier H; Bösebeck F; Franz M; Holtkamp M; Kurlemann G; May TW; Mayer T; Metzner M; Steinhoff BJ; Stodieck S; Straub HB; Weber YG; Brandt C
    Epilepsy Behav; 2018 May; 82():64-67. PubMed ID: 29587187
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Severity of manifestations in tuberous sclerosis complex in relation to genotype.
    Kothare SV; Singh K; Chalifoux JR; Staley BA; Weiner HL; Menzer K; Devinsky O
    Epilepsia; 2014 Jul; 55(7):1025-9. PubMed ID: 24917535
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.